Home Initiation of Buprenorphine in Adolescents with Opioid Use Disorder: A Preliminary Feasibility Study [0.03%]
青少年阿片类物质使用障碍居家接受布施普瑞那治疗初步可行性研究
Sivabalaji Kaliamurthy,Emma Straton,Prianka Kumar
Sivabalaji Kaliamurthy
Background and objectives: The prevalence of opioid use disorder (OUD) among adolescents has increased, yet few adolescents receive medication for OUD (MOUD), particularly buprenorphine. However, initiation can be challen...
Efficacy and Safety of Extended-Release Clonidine Hydrochloride for Attention Deficit Hyperactivity Disorder in Chinese Children and Adolescents: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial [0.03%]
盐酸羟考酮缓释片治疗中国儿童及青少年注意缺陷多动障碍有效性和安全性的多中心、随机、双盲、安慰剂平行对照三期临床试验
Yun Qian,Xiaoyan Ke,Feng Gao et al.
Yun Qian et al.
Introduction: Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition in children and adolescents, yet randomized controlled trial evidence supporting pharmacological treatment in Chine...
Long-Acting Injectable Antipsychotics and Time to Readmission in Early Psychosis [0.03%]
长效抗精神病药物与早期治疗精神病的再入院时间关系研究
Caroline Wang,Sean Lynch,Chaden Noureddine et al.
Caroline Wang et al.
Background: Long-acting injectable (LAI) antipsychotics have demonstrated benefits in reducing relapse and hospitalization in psychotic disorders, yet their real-world impact in early-phase psychosis remains incompletely ...
Knowledge, Skills, Attitudes, and Perceived Barriers Related to Clozapine Use Among Child and Adolescent Psychiatry Professionals: A Cross-Sectional Survey [0.03%]
儿童和青少年精神病学专业人员使用氯氮平的相关知识、技能、态度及感知障碍：横断面调查研究
Mustafa Tuncturk,Dila Mert Kilic,Celal Yesilkaya et al.
Mustafa Tuncturk et al.
Objectives/background: Clozapine is the treatment of choice for treatment-resistant schizophrenia (TRS), yet it remains underutilized in child and adolescent psychiatry. This study aimed to assess knowledge, clinical skil...
Letter: Response to the Letter to the Editor by Dr. Adler and Her Colleagues [0.03%]
致阿德勒医生及其同事的信的回应信
Ema Saito,Rumen Nikolov,Sarah Edwards et al.
Ema Saito et al.
Risperidone Treatment in Children and Adolescents: A Naturalistic Observational Study of Metabolic, Cardiac, and Clinical Outcomes [0.03%]
利培酮治疗对儿童及青少年代谢、心脏及临床结局的自然观察研究
Mesut Sari,Güler Göl Özcan,Yasemin İmrek et al.
Mesut Sari et al.
Background: Risperidone is an atypical antipsychotic commonly used in pediatric psychiatry that may be associated with metabolic and endocrine adverse effects. Prospective data on drug-naive children and adolescents are l...
Letter: Catatonia Treatment in Down Syndrome Regressive Disorder with Repeated Vineland Assessment: A Case Report [0.03%]
关于唐氏综合征退行性疾病的类固醇治疗及 Vineland 评估复查的病例报告(letter)
Niki M Harris,Sarah Marler,Angela Grochowsky et al.
Niki M Harris et al.
d-Amphetamine Transdermal System in Treatment of Children and Adolescents With ADHD: SKAMP Subscale Analysis and Subgroup Analysis from a Pivotal Trial [0.03%]
关于多动症儿童与青少年治疗的d-安非他命透皮给药系统：关键试验中SKAMP次量表分析及亚组分析
Andrew J Cutler,Marina Komaroff,Mariacristina Castelli et al.
Andrew J Cutler et al.
Objectives: d-Amphetamine transdermal system (d-ATS) is FDA-approved for treating attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients ≥6 years. In a pivotal study, d-ATS met its primary (SKAM...
A Retrospective Study of Long-Term Associations of Behavioral Intervention Combined with Medications in Young Children with Attention-Deficit/Hyperactivity Disorder [0.03%]
一项行为干预联合药物治疗注意缺陷多动障碍患儿的长期回顾性研究
Taylor Price,Tanner J Bommersbach,Maria Saliba et al.
Taylor Price et al.
Objective: This study aimed to examine whether parent-child interaction therapy (PCIT), compared with other therapy modalities, was associated with differences in substance use and psychiatric outcomes in a cohort of chil...
Setenay Adıgüzel,Hesham M Hamoda
Setenay Adıgüzel
Background: Selective serotonin reuptake inhibitors (SSRIs) are generally regarded as safe and widely used in children and adolescents. Although rare, SSRIs can cause neuroendocrine side effects such as hyperprolactinemia...